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Abstract
AIM
To summarise the current literature and define patterns 
of disease in migrant and racial groups.
METHODS
A structured key word search in Ovid Medline and 
EMBASE was undertaken in accordance with PRISMA 
guidelines. Studies on incidence, prevalence and disease 
phenotype of migrants and races compared with indig-
enous groups were eligible for inclusion. 
RESULTS
Thirty-three studies met the inclusion criteria. Individual 
studies showed significant differences in incidence, 
prevalence and disease phenotype between migrants or 
race and indigenous groups. Pooled analysis could only 
be undertaken for incidence studies on South Asians 
where there was significant heterogeneity between the 
studies [95% for ulcerative colitis (UC), 83% for Crohn’
s disease (CD)]. The difference between incidence 
rates was not significant with a rate ratio South Asian: 
Caucasian of 0.78 (95%CI: 0.22-2.78) for CD and 
1.39 (95%CI: 0.84-2.32) for UC. South Asians showed 
consistently higher incidence and more extensive UC 
than the indigenous population in five countries. A 
similar pattern was observed for Hispanics in the United 
States. Bangladeshis and African Americans showed an 
increased risk of CD with perianal disease. 
CONCLUSION
This review suggests that migration and race influence 
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the risk of developing inflammatory bowel disease. 
This may be due to different inherent responses upon 
exposure to an environmental trigger in the adopted 
country. Further prospective studies on homogenous 
migrant populations are needed to validate these obser-
vations, with a parallel arm for in-depth investigation of 
putative drivers.
Key words: Epidemiology; Ethnicity; Migration
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: We reviewed the literature on the epidemiology 
of inflammatory bowel disease (IBD) in migrants and 
racial groups. Thirty-three studies met the inclusion 
criteria. Individual studies showed significant differences 
in incidence, prevalence and disease phenotype 
between migrants or race and indigenous groups. Only 
the incidence studies were sufficient in number and 
comparable for pooled analysis and meta-analysis. 
There was a trend for higher incidence for ulcerative 
colitis and lower incidence for Crohn’s disease in South 
Asian migrants. This review suggests that migration and 
race influence the risk of developing IBD. This may be 
due to different inherent responses upon exposure to 
an environmental trigger in the adopted country.
Misra R, Faiz O, Munkholm P, Burisch J, Arebi N. Epidemiology 
of inflammatory bowel disease in racial and ethnic migrant 
groups. World J Gastroenterol 2018; 24(3): 424­437  Available 
from: URL: http://www.wjgnet.com/1007­9327/full/v24/i3/424.
htm  DOI: http://dx.doi.org/10.3748/wjg.v24.i3.424
INTRODUCTION
Ulcerative colitis (UC) and Crohn’s disease (CD) are 
chronic inflammatory bowel conditions, collectively 
known as inflammatory bowel disease (IBD), the 
cause of which is unknown. An exaggerated immune 
response to antigenic stimulation by the gut microbiota 
on a background of genetic susceptibility is thought to 
drive the inflammatory process[1]. 
Epidemiologic studies suggest an increasing inci­
dence and prevalence of IBD in developed countries[2]. 
Although there are fewer epidemiological data from 
developing countries, there appears to be a similar 
trend, fuelling its emergence as a global disease[3,4]. 
Some studies reported on a change in migrants moving 
from developing low incidence countries to developed 
high incidence countries, whereby they exhibit the 
incidence of the adopted country[5,6]. This phenomenon 
is worth exploring further for several reasons. Firstly, it 
implies there may be an environmental trigger for the 
disease as the onset is too rapid to be accounted for 
by genetic changes. Secondly, the demographics over 
the last 50 years have changed due to globalisation 
and significant migration to developed countries[7]. 
Disease presentation following migration offers a unique 
opportunity to further examine how environmental 
factors might influence disease expression in migrants.
Before undertaking further studies on migrant popu­
lations, we sought to summarise the current literature 
on IBD manifestation after migration to developed 
countries. Well­recognised large migrant groups have 
moved from Mexico to the United States and from India 
to the United States, Europe and the Middle East[7]. This 
environmental change can increase the risk of certain 
diseases. For example, the Indian migrant group has 
been studied extensively for cardiovascular disease, 
with associated significant increased risk[8,9]. Migrant 
communities are largely based on colonial and post­
colonial history, cultural and economic ties. When 
relating to diseases, the distinction between migrants, 
ethnic group and race is unclear and yet important[10]. 
The designation of ‘migrants’ refers to people who 
move to a new country as a first generation or second 
generation when born there. Sometimes migrants 
converge and live within a social community based on 
historical and cultural ties (e.g., from India or Pakistan 
to the United Kingdom). The word ‘ethnicity’ derives 
from the Greek word ethnos, meaning a nation, people 
or tribe. It represents a multifaceted concept, with 
emphasis on shared origins or social background, shared 
cultural traditions and common language. Not all ethnic 
groups are migrants, instead the term reflects a social 
categorisation rather than a biological one[10]. In contrast 
the term ‘race’, first described by Hippocrates over 
2000 years ago, classifies man biologically, according to 
physical characteristics such as face shape and colour. 
As there may be an overlap between race, ethnicity and 
migration, we aimed to study the epidemiology of IBD 
in ethnic migrant and racial groups compared with the 
indigenous population. 
MATERIALS AND METHODS
This review was registered on the PROSPERO data­
base, with registration number CRD42014013975. 
A structured search of English language articles in 
the Medline Ovid database from 1946 to October 4th, 
2016 was conducted. The Cochrane database was 
reviewed. The search strategy used the following 
MeSH headings and key words alone or in combination: 
inflammatory bowel diseases, Crohn’s, ulcerative 
colitis, epidemiology, incidence, prevalence, diagnosis, 
migration, race, ethnicity statistics and numerical data 
(Appendix 1). The reference list of identified studies 
and reviews were hand­searched and relevant articles 
included. The search strategy and data extraction was 
performed by two authors (Misra R and Arebi N). Only 
published full­text articles were included.
Study inclusion 
(1) Hospital­ and population­based studies comparing 
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incidence and prevalence of UC and/or CD between 
migrant and indigenous populations; and (2) Studies 
comparing disease phenotype and disease behaviour 
by recognised classification between migrant and 
indigenous populations.
Data extraction
For each study, data was collected on study design and 
location; sampling frame; sample size and ethnic group 
by two authors (Misra R and Arebi N) (Appendices 2 and 
3) For incidence studies, the incidence was measured as 
cases/100000 years. Prevalence was captured as cases 
per 100000. Phenotype was described using Montreal 
classification, with E1 to E3 for UC and by age (A1, A2), 
location (L1, L2, L3, L4) and behaviour (B1, B2, B3, ­p) 
for CD. The proportion of patients with each disease 
phenotype was expressed as percentage for each 
group.
Terminology
The main groups in the studies were described as 
South Asian (SA), Asian, Hispanic, African­American 
and Caucasian. SA was defined by persons with 
a background from the Indian subcontinent: India, 
Pakistan, Bangladesh and Sri Lanka. Asians were 
defined by the continent of Asia, encompassing South 
East Asia and China as well as SA. The term ‘migrant’ 
in this review encompassed recently migrated com­
munities, ethnic groups or race. ‘Ethnic groups’ refers 
to migrants living as communities (e.g., SA in the 
United Kingdom, as statistic registration is recorded 
as an ethnic group). ‘Race’ refers to migrants settled 
as mass communities, where over generations they 
have assimilated with the background communities 
(Hispanics, African­Americans). 
Statistical analysis
The analysis was restricted to studies comparing the 
incidence between migrants and Caucasian groups. 
The incidence of CD and UC were described as rates, 
and pooled as a rate ratio to compare the incidence 
between two groups. 
The χ 2 test for heterogeneity was used to de­
termine whether results from different studies varied 
significantly. Heterogeneity was quantified using the 
I2 statistic, to express the percentage of the variability 
in effect estimates attributed to heterogeneity. The 
p­value from the test of heterogeneity is given, with 
the I2 value. 
As there was significant heterogeneity between the 
studies, and the I2 statistic was high for both CD and 
UC, random effects models were used to assess the 
size of the difference between population groups.
Quality assessment 
The quality of the incidence and prevalence studies 
were assessed by whether the diagnostic criteria 
were clearly defined or recognised criteria were used 
(Lennard­Jones and Copenhagen criteria). The method 
of migrant reporting and sample frame was also 
examined.
RESULTS
The PRISMA flow chart is shown in Figure 1. A total 
of 1181 abstracts were screened. Fifty­two full­text 
articles were retrieved, and 32 met the inclusion criteria 
in comparing incidence and prevalence of IBD and 
disease phenotype and behaviour between migrant and 
indigenous populations. Only 10 studies were suitable 
for the meta­analysis.
 
Description of incidence and prevalence studies 
There were 13 studies identified: 9 measured incide­
nce[5,6,11­17] and 4 reported on prevalence[18­21] (Tables 1 
and 2). Four studies examined both UC and CD[12,13,18,20] 
Eleven of twelve studies were retrospective, and only 
one was prospective[15]. Ten were conducted in single 
centres, with only two multicentre studies. Seven studies 
were carried out in the United Kingdom[5,6,11,14,15,17,18], 
four in North America[12,13,19,20] and the others in Fiji and 
Singapore[16,21]. The prevalence of IBD in the United 
Kingdom was only reported in one study[18]. 
Study quality characteristics
Quality characteristics of the studies are shown in Tables 
1­3. One study looked at CD and UC incidence, and two 
studies looked at CD and UC prevalence. Six of thirteen 
studies used recognised diagnostic criteria[5,6,12,15,17,21]. 
Migrant status was self-reported in five studies[11,15,18,20,21] 
and taken from medical records in six studies[6,12­14,16,19]. 
Two studies relied on patient surname to identify 
migrant origin[5,17]. The sample frame was population­
based in six[5,13,15,17,18,20] and hospital­based in seven 
studies[6,11,12,14,16,19,21].
Incidence of CD
Most studies reporting the incidence of CD (3/5) were 
from the United Kingdom (Table 1), with a predominant 
SA migrant group[6,11,17]. The remaining two studies 
from Canada described the SA paediatric population[12], 
and one study compared non­immigrants to SA[13]. 
The incidence of CD in SAs was consistently lower than 
Caucasian, except for one Canadian paediatric study[12]. 
The Benchimol study showed a lower incidence in 
SA compared to other groups within the same envir­
onment[13]. The two United Kingdom studies where the 
incidence was examined over two time periods showed 
an increase in the incidence of CD in the SA population, 
from 1.2 to 2.3/100000 in East London and 1.2 to 
3.1/100000 in Leicester[6,17]. The last migrant United 
Kingdom incidence studies were published in 1989. 
Incidence of uC
There were six studies reporting the incidence of UC 
(Table 1). The incidence was higher for SAs when 
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(Table 4). All but one study reported a higher incidence 
for UC in SA. In the outlier study[9], the population 
was exclusively a Bangladeshi subgroup of the SA 
population, unlike the other studies where the popu­
lation was predominantly North Indian.
Prevalence of CD
Three studies reported on CD prevalence. Two were 
from the United States, where the prevalence rate for 
Asian, Black or Hispanic populations was lower than 
for Caucasians[19,20] (Table 2). The remaining study 
from the United Kingdom showed a lower prevalence 
in Caucasians than SA compared to Caucasians[18]. This 
is consistent with the reportedly lower SA CD incidence 
from the same population in Leicester at approximately 
the same time period[17] (Table 1).
Prevalence of uC
There were four studies reporting on UC prevalence, 
with diverging results (Table 4). The only United 
Kingdom study showed a higher prevalence for UC in 
SAs compared with the local population[18]. A separate 
study from Singapore reported a higher prevalence 
in SAs than Chinese and Malay groups[21]. In contrast 
in the United States, the UC prevalence was lower 
for Asians, Hispanics and Blacks compared with the 
Caucasian group[20].
Description of disease phenotype studies
There were 20 studies examining disease phenotype 
compared with Caucasians (three studies) and Mela­
nesians in one study from Fiji[5,12,15,16]. In the only 
prospective study, the incidence was significantly higher 
and although this was a small study (74 cases) it was 
also the most recent[15]. This may indicate a rising 
incidence. Two studies showed a lower UC incidence, 
one in the Bangladeshi population in East London[14] 
and the other in Ontario, Canada[13]. 
Meta-analysis of CD incidence studies
We performed a meta­analysis on studies comparing 
SA migrant and Caucasian groups, which consisted 
of four studies. Two studies looked at incidence over 
2 separate decades. Each decade was counted as a 
separate study and the analysis was undertaken as six 
studies[5,6]. The Benchimol study[13] was excluded as the 
comparator group and was classified as non-immigrant 
rather than a specifically named ethnic/migrant group. 
The overall rate ratio for CD (0.78, 95%CI: 0.22­2.78) 
showed a trend towards a lower incidence in the 
adult SA group in comparison to the Caucasian group 
(Table 4). The individual studies all showed lower 
incidence rates, except for one study in a paediatric 
population which showed a higher incidence in the SA 
population[12].
Meta-analysis of uC incidence studies
Analysis of the four studies for UC showed an overall 
rate ratio of 1.39 (95%CI: 0.84­2.32), indicating a 
trend towards a higher rate of UC in the SA population 
Records identified through 
database search (n  = 1476)
Additional records identified 
through other sources (n  = 7)
Records after duplicates removed 
(n  = 1181)
Records screened 
(n  = 1181)
Records excluded 
(n  = 1129)
Full-text articles assessed 
for eligibility (n  = 52)
Studies included in qualitative 
synthesis (n  = 33)
Studies included in 
quantitative synthesis 
(meta-analysis) (n  = 10)
19 full-text articles excluded due to:
No comparative incidence or prevalence data between migrant and 
indigenous groups of UC/Crohn’s (n  = 10)
Comparison of IBD cases rather than UC or Crohn’s (n  = 2)
No comparative phenotypic data (n  = 1)
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Figure 1  PRISMA flowchart. IBD: Inflammatory bowel disease; UC: Ulcerative colitis.
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in relation to migrants or race (Tables 5­9). Fourteen 
studies were conducted in the United States[22­34] and 
four in the United Kingdom[15,35­37], with the remaining 
two from Canada and Malaysia[38,39]. Sixteen studies 
were single centre, three multicentre[24,31,35] and only one 
was prospective[15]. Majority of the studies reported on 
both UC and CD, with 15 reporting on UC and 16 on CD. 
CD
The phenotype was studied for location and behaviour. 
Comparisons are presented for SA, African­Americans 
or Hispanics and Caucasians depending on the country 
where the studies were conducted. 
SA group was compared with Caucasians in four 
studies and all reported on both location and disease 
Table 1  Incidence of Crohn’s disease and ulcerative colitis
Study characteristics and demographics Study quality characteristics
Study Country (region) Study period Number 
of cases
Incidence rate/100000 Diagnosis based on 
recognised criteria 
Ethnicity reporting 
method
Sample frame
SA Caucasian
Crohn's disease
   Fellows (1985)[11] United Kingdom 
(Derby)
1966-1985     221   4.4   7.5 No Self-reported Hospital
   Probert (1992)[6] United Kingdom 
(East London)
1970-79       45   1.2   3.8 Yes Medical records Hospital
1980-89       54   2.3   3.8
   Jayanthi (1992)[17] United Kingdom 
(Leicester)
1972-1980       80   1.2   3.5 Yes Surname Population
1981-1989     104   3.1   5.3
   Pinsk (2007)[12] Canada (Vancouver) 1985-2005 397 (Paed)   6.7   1.0 Yes Medical records Hospital
   Benchimol1 (2015)[13] Canada (Ontario) 1994-2010 12113   5.0 11.3 No Medical records Population
Ulcerative colitis
   Probert (1992)[5] United Kingdom 
(Leicester)
1972-1989   1003 10.8   5.3 No Surname Population
   Jayanthi (1992)[14] United Kingdom 
(East London)
1972-1989     112   1.8   6.2 No Medical records Hospital
   Carr (1999)[15] United Kingdom 
(Leicester)
1991-1994       74 17.2   9.1 Yes Self-reported Population
   Pinsk (2007)[12] Canada (Vancouver) 1985-2005 120 (Paed)   6.4   3.7 No Medical records Hospital
   Probert (1985)[16] Fiji 1985-1986       15   1.5   0.2 No Medical records Hospital
   Benchimol1(2015)[13] Canada (Ontario) 1994-2010 12713   2.0 11.4 No Medical records Population
1SA compared to non-immigrant. Characteristics of studies comparing South Asian (SA) migrants and Caucasians. 
Table 2  Prevalence of Crohn’s disease: Study characteristics and comparison between Caucasian and other migrant groups
Study characteristics Study quality characteristics
Study Country (region) Study period Number 
of cases
Prevalence rate, cases/100000 Diagnosis based 
on recognised 
criteria 
Ethnicity 
reporting 
method
Sample 
frame
SA Asian Caucasian Black Hispanic
Probert 
(1993)[18]
United Kingdom 
(Leicester)
1989 676 33.2 - 75.8  -  - Yes Self-reported Population
Kurata 
(1992)[19]
United States 
(California)
1982-1988 169 -   5.6 43.6 29.8 4.1 No Medical records Hospital
Wang  
(2013)[20]
United States 
(National Database)
1996-2007 204 - 45.0 154.0 68.0 15.0 No Self-reported Population
SA: South Asian.
Table 3  Prevalence of ulcerative colitis: Study characteristics and comparison between population groups
Study characteristics Study quality characteristics
Study Country (region) Study 
period
Number 
of cases
Prevalence rate, cases/100000 Diagnosis based on 
recognised criteria 
Ethnicity reporting 
method
Sample 
frame
SA Asian Caucasian Black Hispanic
Probert 
(1993)[18]
United Kingdom 
(Leicester)
1989 888 136.0 - 90.8 -  - Yes Self-reported Population
Wang 
(2013)[20] 
United States 
(National database)
1996-2007 108 - 40.0 89.0 25 35 No Self-reported Population
SA Malay Chinese Black Hispanic
Lee 
(2000)[21]
Singapore 
(Singapore)
1985-1996   58      16.2 7.0   6.0  -   - Yes Self-reported Hospital
SA: South Asian.
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behaviour (Table 5). Two were from the United King­
dom[35,36], one from the United States[22], and one from 
Canada[38]. Two studies (United Kingdom and Canada) 
showed SA significantly more likely to have colonic 
disease[35,38]. These two studies contained 947 cases of 
the 1147 pooled population. The Canadian study also 
showed that SA had less ileal involvement[38]. There was 
no other significant difference in disease location. For 
behaviour, one United Kingdom study showed SA had 
less stricturing (B2) and less non­penetrating disease 
(B3), but this was not significant[35]. In contrast, perianal 
disease was significantly more common in SA compared 
with Caucasians in two studies[22,36]. The Canadian 
paediatric study, which included 638 cases, indicated a 
more complicated disease behaviour for SA, where B2 
and B3 disease was noted in 21% of SA compared with 
9% of Caucasians[38]. 
African­American and Caucasian groups were 
compared for disease location in eight studies (Table 
6), all from the United States, three of which were in 
paediatric populations[25,26,29]. Disease behaviour in 
eight studies is shown in Table 7. African­Americans 
showed significantly less ileal disease (L1) in three 
studies[23,24,40] from a population of 2241 cases (65%) 
out of the total cohort of 3467 cases studied. African­
Americans showed more significantly more stricturing 
(B2) and penetrating disease (B3) in one study[25] and 
perianal disease in two studies[24,31] (Table 7).
Hispanic and Caucasians were compared for disease 
location in only three studies (Table 6) and behaviour 
in four studies (Table 7). Hispanics showed significantly 
lower rates for ileal disease and higher rate of colonic 
disease compared with Caucasians in one study po­
pulation of 697 cases[24]. Perianal presentation was 
Table 4  Meta-analysis of incidence studies showing rate ratio of South Asians relative to Caucasians
Disease Number of studies Heterogeneity Effect size
I 2 P  value RR (95%CI) P  value
Crohn’s disease 6 95% < 0.001 0.78 (0.22, 2.78) 0.7
Ulcerative colitis 4 83% 0.001 1.39 (0.84, 2.32) 0.2
Table 5  Crohn’s disease location and behaviour
Study Country (Region) Time period Number of cases Montreal classification Population groups, %
SA Caucasian 
Location
   Walker (2011)[35] United Kingdom (NW London) 2008-2010 309 L1 16.0 24.7
L2 46.8 34.8
L3 37.2 40.5
L4 0.0 0.0
   Goodhand (2012)[36] United Kingdom (East London) 2010 141 L1 33.0 32.0
L2 24.0 43.0
L3 38.0 22.0
L4 18.0 13.0
   Li (2013)[22] United States (San Francisco) 1994-2009 57 (Paed) L1 7.7 14.9
L2 38.5 23.4
L3 53.9 61.7
L4 15.4 5.3
   Carroll (2016)[38] Canada (British Columbia) 1997-2012 638 (Paed) L1 6.0 9.0
L2 55.0 35.0
L3 39.0 55.0
L4a 55.0 43.0
L4b 1.0 9.0
L4ab 0.0 8.0
Behaviour
   Walker (2011)[35] United Kingdom (NW London) 2008-2010 309 B1 72.3 58.1
B2 22.0 60.0
B3 4.3 14.0
Perianal 20.2 21.4
   Goodhand (2012)[36] United Kingdom (East London) 2010 141 B1 63.0 55.0
B2 15.0 11.0
B3 20.0 15.0
Perianal 16.0 3.0
   Li (2013)[22] United States (San Francisco) 1994-2009 57 (Paed) Perianal 46.2 12.8
   Carroll (2016)[38] Canada (British Columbia) 1997-2012 638 (Paed) B1 61.0 73.0
B2 13.0 16.0
B3 6.0 3.0
B2B3 21.0 9.0
South Asians compared with Caucasians. Total No. of cases reported was 1145. Significant difference in disease behaviour illustrated in bold.
Misra R et al . Ethnicity, race and epidemiology of IBD
430 January 21, 2018|Volume 24|Issue 3|WJG|www.wjgnet.com
significantly more frequent in Hispanics in only 2/4 
studies but these studies represented 92% of the 
studied cohorts (7376/7974)[24,31]. In another study of 
325 cases, they were significantly less likely to have 
upper gastrointestinal disease[28]. 
uC
The UC studies described disease extent. Results were 
presented for SA, African­Americans or Hispanics 
compared with Caucasian or indigenous adult and 
paediatric populations (Tables 8 and 9). SA and Cau­
casian (or Malay in one study) groups were compared in 
six studies, including four in the United Kingdom[15,35­37] 
and one in Malaysia[39] and a further study in Canada 
which was limited to a paediatric population[38] (Table 8). 
In all six studies there were more SA with pan­colonic 
disease than Caucasians; this was a significant finding 
in four studies[35,36,38,39], which represented 898/1054 
cases (85%) of the pooled population.
African­Americans were compared to Caucasians 
in six studies, of which two were paediatric (Table 9). 
Four studies described a higher proportion of African­
Americans having disease limited to the rectum[25,26,32,33], 
which was a significant finding in one study[33]. 
Hispanics were compared with Caucasians in four 
studies. In the Hispanic group, two studies showed 
no difference in disease location for UC[26,28], another 
significantly less proctitis[32], with a fourth study demon­
strating a significantly increased risk of pan-colitis and 
higher colectomy rate (32.3% vs 15.8%, p < 0.01)[24].
DISCUSSION
This review indicates a difference in disease incidence, 
prevalence and phenotypes between migrants and non­
migrants in individual studies. This has two important 
implications. Firstly, increased migration may alter 
disease burden within a population and impact health 
policy decisions. Secondly, deeper investigation of 
migrant populations may provide insight into the role of 
environmental change and diet in the aetiology of IBD. 
We identified the main migrant populations with IBD 
reported in the literatures as SA, African­Americans and 
Hispanics. The SA population has a wide diaspora and 
countries such as United Kingdom, Canada, Singapore, 
Malaysia and Fiji report the presentation of IBD. 
The SA group seems to be particularly susceptible 
to developing UC, with a higher incidence than the 
local population in the United Kingdom and Canada. 
The incidence was only lower in two populations. 
The first was in east London, which was restricted 
to the Bangladeshi group and therefore may be a 
reflection of a distinct ethnic group. The second was 
in Ontario, Canada, which compared SA to the non­
Table 6  Crohn’s disease location
Study Country (Region) Time period Number of cases Disease location/ 
Behaviour, Montreal
Population groups, %
AA Caucasian (or other control) Hispanic
Cross (2006)[23] United States (Baltimore) 1997-2005 210 L1 13.0 38.0  - 
L2 29.0 23.0  - 
L3 56.0 36.0  - 
Sofia (2014)[40] United States (Chicago) 2008-2013 1334 L1 57.8 71.0  - 
L2 60.6 66.0  - 
Nguyen 
(2006)[24]
United States (National) 2003-2005 697 L1 16.1 29.2 23.3
L2 33.9 17.4 16.3
L3 22.6 36.7 52.3
L4 27.4 16.7 8.1
Eidelwein 
(2007)[25]
United States (Baltimore) 1991-2000 137 (Paed) L1 3.0 2.9  - 
L2 73.5 71.8  - 
L3 23.5 25.2  - 
Hatter (2012)[26] United States (Texas) 2004-2009 246 (Paed) L1 4.3 4.7 4.8
L2 7.1 4.8 10.5
L3 87.8 88.9 84.2
Ghazi (2013)[27] United States (Baltimore) 2004-2009 296 L1 31.0 38.0  - 
L2 12.0 20.0  - 
L3 55.0 42.0  - 
Damas (2013)[28] United States (Florida) 1998- 2009 325 L1  - 16 (NHW) 24.4
L2  - 24.0 25.6
L3  - 60.0 50.0
L4  - 12.5 3.9
Kugathasan 
(2003)[29]
United States (National) 2000-2001 222 (Paed) L1 10.0 19.0  - 
L2 34.0 28.0  - 
L3 46.0 51.0  - 
L4 32.0 42.0  - 
AA or Hispanics compared with Caucasians (3467 total cases). Bold font shows significant differences between AA and population group. Italic font 
illustrates significant difference between Hispanic and Caucasian groups. AA: African-Americans; NHW: Non-Hispanic white.
Misra R et al . Ethnicity, race and epidemiology of IBD
431 January 21, 2018|Volume 24|Issue 3|WJG|www.wjgnet.com
immigrant population[13]. The non­immigrant population 
had a higher UC incidence rate (11.4/100000) than 
the Caucasian group in the other Canadian study 
(3.7/100000). A possible explanation is that immig­
ration data was only available from 1985 onwards. 
Immigrants who arrived to Canada before 1985 were 
considered as non­immigrants. It is noteworthy that the 
likelihood of UC increased the younger age of arrival of 
the immigrant. 
Whilst there were fewer studies on prevalence, 
both reported higher prevalence for SA as would be 
expected for the higher incidence rate[18,21]. When 
the data was pooled, the summary measures also 
illustrated a trend towards a higher rate of UC in the 
SA population compared to Caucasians (Table 4). The 
outlier study consisted of a Bangladeshi ethnic group, 
and excluding this study showed a consistently higher 
incidence of UC in SA; but, we did not repeat the 
meta­analysis on the three remaining studies as the 
result would be questionable, due to bias and error.
Table 7  Crohn’s disease behaviour
Study Country (Region) Time period Number of 
cases
Disease location/ 
Behaviour, Montreal
Population groups, %
AA Caucasian Hispanic
Nguyen (2006)[24] United States (National) 2003-2005 697 B1 53.2 48.0 45.3
B2 27.9 21.4 23.6
B3 19.0 30.6 31.1
Perianal 40.0 28.7 52.5
Eidelwein (2007)[25] United States (Baltimore) 1991-2000 137 (Paed) B2 + B3 29.1 11.11  -
Ghazi (2013)[27] United States (Baltimore) 2004-2009 296 B1 18.0 33.0  - 
B2 42.0 36.0  - 
B3 40.0 31.0  - 
Perianal 36.0 25.0  - 
Sofia (2014)[40] United States (Chicago) 2008-2013 1334 Perianal 25.7 24.7  - 
Damas (2013)[28] United States (Florida) 1998- 2009 325 B1  - 81.5 (NHW) 78.9
B2  - 0.0 1.1
B3  - 18.5 20.0
Perianal  - 27.0 23.0
Kugathasan (2005)[29] United States (National)   - 222 (Paed) Inflammatory 58.0 64.0  - 
Stricturing 20.0 18.0  - 
Fistulising 22.0 18.0  - 
Perianal 23.0 36.0  - 
Malaty (2010)[30] Houston (Texas) 2000-2006 273 Inflammatory 64.0 63.0 58.0
Stricturing 16.0 17.0 13.0
Fistulising 17.0 16.0 32.0
Adler (2016)[31] Multicentre (United States 
and United Kingdom)
2006-2014 2034 (Paed) Perianal 26.0 20.0 24.0
AA or Hispanics compared with Caucasians (5318 cases). Italic font illustrates significant differences between hispanic and population group. Bold font 
shows significant differences between AA and other population group. AA: African-Americans.
Table 8  Ulcerative colitis in Caucasian and South Asian migrant groups (1054 cases)
Study Country (Region) Study period Number of cases Disease extent, Montreal Ethnic groups, %
SA Caucasian (or other control) 
Adult
   Carr (1999)[15] United Kingdom (Leicester) 1991-1994   74 E1 + E2 63.7 68.3
E3 36.3 31.7
   Rashid (2008)[37] United Kingdom (Manchester) 2008   82 E3 41.0 26.0
   Walker (2011)[35] United Kingdom (NW London) 2008-2010 461 E1 9.9 26.1
E2 27.1 31.4
E3 63.0 42.0
   Goodhand (2012)[36] United Kingdom (East London) 2010   89 E1 2.0 31.0
E3 60.0 33.0
   Hilmi (2009)[39] Malaysia (Malaysia) 2004-2005 118 E1 + 2 39.6 56.7 (Malay)
E3 60.4 43.4 (Malay)
Paediatric
   Carroll (2016)[38] Canada (British Columbia) 1997-2012 230 E1 3.0 5.0
E2 9.0 19.0
E3 12.0 18.0
E4 77.0 58 (Non-South Asian)
Adult and paediatric studies on disease extent. Bold font shows significant differences between AA and population group (809/1054 cases). AA: African-
American; SA: South Asian.
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Data on African­Americans and Hispanics was 
limited for disease incidence and prevalence, and no 
conclusions could be drawn. Only one study from the 
United States described UC prevalence in African­
Americans and Hispanics, which was lower for each 
group than the Caucasian population[20]. Two separate 
disease phenotype studies in Hispanics reported less 
proctitis in one and more colonic disease in the other. 
The parallel results would suggest that the Hispanic 
race exhibits more extensive disease. Disease extent 
was different for African­Americans, as the only study 
reporting on it showed that most African­Americans 
had rectal disease. Similar to the Hispanic group, the 
large SA population showed significantly more pan­
colonic disease. Overall, these findings imply a higher 
rate of colonic disease in Hispanics and SA migrants.
An interesting observation borne out by studies in 
Leicester, North West London and British Columbia[18,35,38] 
is that the well documented increase in pan­colonic 
disease did not translate into higher colectomy rate, as 
would be expected. However, the two Hispanic studies 
in this review showed more colonic disease, and the 
one that studied colectomy rate reported a higher 
colectomy rate for UC as would be expected with a 
higher prevalence of pan­colonic disease[24]. 
In addition, we recently published data generated 
from a national database showing a higher rate of 
colectomy in a SA cohort in the United Kingdom[41]. 
In contrast to the UC incidence rate, the incidence 
of CD seems to be consistently lower in SA than 
Caucasians. Only one study showed a higher incidence 
rate[12]. This was a paediatric population, where the 
incidence of CD in the background population was 
much lower (1.0/10000) than in a parallel Canadian 
study (11.3/100000). It is plausible to speculate 
that it may reflect earlier disease onset for second 
generation migrants. The meta­analyses suggested 
no strong evidence of a difference in the incidence of 
the pooled CD data. Were the outlier study by Pinsk 
et al[12] to be excluded, there would be a consistently 
lower incidence of CD in SAs. The lower prevalence 
in the United Kingdom is consistent with the lower 
CD incidence for SA. In the United States, prevalence 
for Asians was lower but this group is broader and 
includes South East Asians and Pacific Asians. 
The phenotypic pattern shows more colonic, less 
ileal disease, more perianal and more penetrating and 
stricturing disease in SA, with evidence collated from 
different studies. The two independent observations 
of more colonic disease and perianal disease in SA are 
supportive of more aggressive disease in this group. 
Similarly, the African-Americans had significantly less 
TI disease, inferring more colonic disease. There was 
more perianal disease, and even though this stems 
from only two studies, they represent 65% of the 
studied cases. The Hispanics also show more colonic 
and perianal disease. Overall, migrants seem to be 
less likely to have CD, but when it presents it tends to 
be more aggressive with colonic and perianal location 
and complex behaviour. 
The prevalence studies show UC and CD to be 
more prevalent in Caucasians compared to Black and 
Hispanic groups and UC is more common in SA groups. 
Comparing the two CD United States studies[19,20], a 
Table 9  Ulcerative colitis in AA and Hispanic groups (1787 cases)
Study Country (Region) Time period Number of cases Disease extent Ethnic groups, %
AA Caucasian Hispanic
Adult studies
   Basu (2005)[32] United States (Texas) 1999-2003   61 E1  - 32.0 8.0
E2 + 3  - 68.0 86.0
   Nguyen (2006)[24] United States (National database) 2003-2005 396 E1 13.8 5.9 3.6
E2 16.4 31.4 34.5
E3 51.7 62.7 80.0
   Eidelwein (2007)[25] United States (Baltimore) 1991-2000   40 E1 + 2 0.0 10.0  - 
E3 100.0 23.0  - 
   Moore (2012)[33] United States (Ohio) 2000-2010 311 E1 14.5 6.5  - 
E2 44.7 30.7  - 
E3 40.8 62.9  - 
   Sofia (2014)[40] United States (Chicago) 2008-2013 541 E1 17.9 11.1  - 
E2 28.6 32.0  - 
E3 50.0 51.5  - 
   Damas (2013)[28] United States (Florida) 1999-2009 138 E1  - 11.8 12.5
E2  - 29.4 46.2
E3  - 58.8 41.3
Paediatric
   Flasar (2008)[34] United States (Baltimore) 1997-2005 197 E1 23.0 10.0  - 
E2 23.0 31.0  - 
E3 53.0 59.0  - 
   Hatter (2012)[26] United States (Texas) 2004-2009 103 E1 + 2 7.1 15.4 18.8
E3 81.3 84.6 81.3
Adult and paediatric studies on disease extent. Italic font illustrates significant difference between Hispanic and Population group. Bold font shows 
significant differences between AA and population group. AA: African-American.
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significant increase in prevalence was shown over time 
in all groups. There has only been one United Kingdom 
prevalence study, which was performed in 1989, and 
the last United States study was over 10 years ago. 
Newer studies are needed to update the emergence of 
disease. 
Differences in phenotype were noted between 
first and second generation SA migrants. In second 
generation migrants in Leicester, extensive colitis was 
more common than in the first generation, which 
was similar to that seen in Caucasians[15]. The disease 
pattern followed that of the indigenous population 
after only one generation and conveys the influence of 
environmental factors on disease expression. However, 
these findings were not replicated in Northwest London 
less than a decade later. UC disease phenotype in 
first generation SA diagnosed within 10 years of 
migration was similar to second generation SA, even 
though the dominant phenotype was extensive colitis 
in both generations[35]. When the authors performed 
a subgroup analysis on first generation patients, the 
rates of diagnosis in the first, second and third decades 
after migration were comparable and, somewhat unex­
pectedly, there was no significant increase in disease 
diagnosis with time spent in the United Kingdom. This 
result, in conjunction with similar disease phenotype, 
led the authors to speculate that perhaps genetic 
susceptibility had a more important role to play. Indeed, 
novel UC risk alleles have been identified specifically 
in the North Indian population[42]. A recent genome­
wide specific study has shown African­specific loci for 
UC[43], demonstrating the importance of studying non­
European populations to better understand the disease.
Limitations of the study
The quality assessment of the incidence and prevalence 
studies revealed significant weaknesses in the body of 
evidence. Almost all the studies are retrospective and, 
therefore, subject to case ascertainment bias. Only six 
of thirteen studies used recognised diagnostic criteria, 
and the majority of the studies were hospital­ rather 
than population­based and relied on ethnicity repor­
ting through medical records or surname recognition. 
There is a risk of information bias as data may have 
been collected by different people, especially in the 
studies spanning a longer time period. Differential loss 
of follow up is also another source of bias. 
Standard disease classification systems, such as 
Montreal classification, were not used in all studies. 
Moreover, the prevailing studies have failed to address 
several confounding variables­medication, smoking, 
diet, patient choice and clinical decision­making, all 
of which could affect disease phenotype­and other 
markers of severe disease, such as requirement for 
surgery. Moshkovska et al[44] demonstrated that SA 
patients had significantly higher concerns with 5-ASA 
treatments than non­Asian patients, and SA ethnicity 
was independently associated with non­adherence, 
which is relevant as differential exposure to 5­ASA may 
contribute to more extensive disease. Diagnostic delay 
increases the risk of Crohn’s­related surgery[27], and 
if access to medical care is limited for certain ethnic 
groups, it may explain a more aggressive phenotype. 
Smoking habits differ between ethnic groups. For 
instance, in the United Kingdom, an estimated 40% 
of Bangladeshi men regularly smoke compared to the 
national average of 24%[45]. This would be expected 
to increase susceptibility to Crohn’s rather than UC in 
this group and would may explain the predominant 
perianal phenotype observed in Bangladeshis in East 
London[36].
The other limitation rests with terminology and 
terms used within each study, depending on the po­
pulation studied. ‘Hispanic’ is a broad term that can 
include people from Mexico, Puerto Rico or Cuba. This 
is an example of a social construct of Hispanic ethnicity, 
which may not reflect the genetic background of the 
population. Better categorisation of these groups, 
according to country of origin, is required to determine 
whether there are differences. In the African­Americans, 
the distinction between whether the patients were 
migrants or second generation was not clear and as we 
have seen in the SA group, this can impact on disease 
phenotype. Apart from the SA group, the phenotypic 
studies do not show clear differences in comparison to 
Caucasians. Within the Hispanic and African­American 
groups, the phenotypic results are discordant, which 
may reflect the heterogeneity of the population.
This review, with its attendant limitations, de­
monstrated the absence of high­quality, prospective, 
population­based epidemiological studies on this topic. 
The ACCESS[4] and Epicom[46] studies are exemplary 
recent prospective multicentre cohorts studies that 
generated new insights into the incidence of IBD 
in Asia­Pacific and Europe; however, they did not 
report on migrants. We, subsequently, conducted a 
retrospective review of the Epicom study population, 
whereby migrant status was re­examined. We noted a 
higher than expected incidence of IBD in the migrant 
population, even though the number of migrants in 
the majority of countries was still low[47]. Conversely, 
a recent paper describing the study of movement 
of migrants from high to low incidence areas (Faroe 
Islands to Denmark) has shown a significant impact on 
UC disease risk. Excess risk of UC was nearly doubled 
during the immigrants’ first 10 years, but after 10 years 
the immigrants’ UC risk was similar to that of Danes. 
In this study, the removal of an unknown exposure has 
caused a dramatic shift in the incidence, emphasising 
the importance of environmental factors[48].
The key change with migration is exposure to a 
different environment. This may be driven by factors 
that change with urbanisation, namely diet, lifestyle 
(smoking, alcohol) and hygiene, among others. The 
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diet and its change with migration deserves further 
examination. Where migrants form an ethnic enclave, 
it may remain unaltered. When they integrate with 
the local population, they may adopt the prevailing 
western diet. Exposure to western diet can be studied by 
its migration to the east. This tends to be associated 
with rapid urbanisation, as seen in areas such as 
Guangzhou, China, where the incidence of IBD has 
recently risen[4]. 
Mounting evidence from animal models and human 
studies indicates an overarching effect of diet on the gut 
microbiota. Agus et al[49] showed how a western diet 
induces changes in gut microbiota composition, alters 
host homeostasis and promotes adherent invasive gut 
colonisation in genetically­susceptible mice. In healthy 
volunteers, 2 wk of either exclusive animal or plant 
product consumption altered the microbial community 
structure and overcame inter­individual differences in 
microbial gene expression[50]. In migrant populations, 
dietary change may exert a more profound aetio­
pathogenic effect, which is largely unexplored in this 
population group in conjunction with a dearth of detailed 
dietary data on ethnic groups with IBD. Accurate 
dietary data is difficult to obtain without an interviewer-
led, time­consuming questionnaire. Large scale epide­
miological studies often neglect this area in favour of 
collecting other and easily accessible information. 
Studying the diet in migrant populations may provide 
clues to modifiable risk factors in the development of 
IBD. Whilst this may appear to be straightforward, 
in reality it is challenging to explore because patients 
significantly change their diets at diagnosis, with 
consequential effects on microbial composition[51]. This 
confounder needs to be recognised and minimised when 
studying ethnicity and alterations in the microbiota 
by recording supervised dietary intake. Other envir­
onmental factors, such as urbanisation and hygiene, 
may also influence the microbiome but studying how 
they do so is more challenging. We suggest looking at 
the endpoint of genetic and environmental factors by 
examining the function of microbiota through metabolic 
profiles in migrant patients. 
A link between distinct microbial patterns and mig­
ration may partly explain the differences in disease 
phenotype described in this review. Two studies reported 
different microbial profiles for ethnic groups[52,53]. A 
further study demonstrated that these compositional 
differences can drive metabolic and immune activities, 
which can be related to disease severity[54]. Confounders 
such as smoking, diet, medications, disease pheno­
type and severity that affect the microbiota were not 
analysed separately within these studies, due to the 
small numbers of patients. 
The potential role of environmental factors on mic­
robial colonisation is an area of increasing interest[55]. 
Studying these early life perturbations in a genetically 
predisposed population, such as second generation 
migrants, bought up in a ‘western’ environment, for 
example SA, may help to decipher the impact of genetic 
and environmental factors. A prospective inception 
cohort to describe real­time epidemiological features 
of IBD will address the limitations observed in this 
systematic review. Parallel in­depth analysis of microbial 
factors may show a specific microbial profile related to 
migration and explain the differing disease phenotype, 
whilst addressing the confounding factors.
ARTICLE HIGHLIGHTS
Research background
Epidemiologic studies suggest an increasing incidence and prevalence of 
inflammatory bowel disease (IBD) in developed countries. Some studies have 
reported a change in migrants moving from developing low incidence countries 
to developed high incidence countries, whereby they exhibit the incidence of 
the adopted country. This implies there may be an environmental trigger for the 
disease, as the onset is too rapid to be accounted for by genetic changes.
Research motivation 
Disease presentation following migration offers a unique opportunity to examine 
how environmental factors might influence disease expression in migrants. 
Describing epidemiological changes in migrant groups may identify susceptible 
ethnic groups and help target further studies.
Research objectives 
The authors sought to summarise the current literature on IBD manifestation 
after migration to developed countries. As there may be an overlap between 
race, ethnicity and migration, we aimed to study epidemiology of IBD in ethnic 
migrant and racial groups compared with the indigenous population. 
Research methods
A systematic review using PRISMA guidelines was undertaken. Studies on 
incidence, prevalence and disease phenotype of migrants and race compared 
with indigenous groups were eligible for inclusion. A statistical meta-analysis 
comparing the incidence between migrants and Caucasian groups was 
performed.
Research results
Thirty-three studies met the inclusion criteria. South Asians showed consistently 
higher incidence than indigenous groups for ulcerative colitis (UC). Pooled 
analysis could only be undertaken for incidence studies on South Asians 
compared to Caucasians. There was significant heterogeneity between the 
studies [95% for UC, 83% for Crohn’s disease (CD)]. The difference between 
incidence rates was not significant, with a rate ratio for South Asian:Caucasian 
of 0.78 (95%CI: 0.22-2.78) for CD and 1.39 (95%CI: 0.84-2.32) for UC. In 
six studies, there were more South Asians with pan-colonic disease than 
Caucasians, and this was a significant finding in four studies. A similar pattern 
was observed for Hispanics in the United States. Bangladeshis and African-
Americans showed an increased risk of CD with perianal disease. 
Research conclusions
This the first study to show consistent differences in disease incidence, 
prevalence and phenotypes between migrants and non-migrants. The South 
Asian migrant population are particularly susceptible to developing UC. This 
review has demonstrated the absence of high-quality, prospective, population-
based epidemiological studies on this topic. Investigation of migrant populations 
may provide insight into the role of environmental change and diet in the 
aetiology of IBD. 
Research perspectives
A prospective inception cohort to describe real-time epidemiological features 
of IBD will address the limitations observed in this systematic review. The 
potential role of environmental factors on microbial colonisation is an area of 
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increasing interest. Studying second generation migrants bought up in a ‘western’ 
environment, for example South Asians, may help to decipher the impact of 
genetic and environmental factors. Parallel in-depth analysis of microbial factors 
may show a specific microbial profile related to migration and explain differing 
disease phenotype, whilst addressing confounding factors.
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